Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Menopause affects hair and skin; more research needed for treatment.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

Both estrogens and androgens are important for health in both males and females.

Nanotechnology improves Clomiphene citrate's effectiveness and reduces side effects for treating ovulatory disorders.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Lifestyle changes and clomiphene are first-line treatments for infertility in women with PCOS, with other options available if these fail.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

A group has developed therapies that show promise for treating cancer and various other conditions.